Synonyms: WEHI 164, WEHI164, WEHI 164 TC
WEHI-164 is a mouse fibrosarcoma cell line derived from a tumor induced by subcutaneous injections of 3-methylcholanthrene(1). The model is suitable for efficacy and PD testing of anti-cancer immunotherapeutics in vivo. At CrownBio, the WEHI-164 model is available subcutaneously.
Response to Immune Checkpoint Inhibitors
(1) Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells. Proc. Soc. Exp. Biol. Med. 144:813-818, 1973.